• Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Tweet Tweets with this article
    • Missed this from @56deanstreet 30% with newly acquired HIV has M184V if recent oral PrEP exposure vs 1% if none. We need effective PrEP that doesn't impact future treatment; my fear is IM-CAB may do just that #IDtwitter #HIVtwitter #PrEP good work 56DS!! https://t.co/Vd0aO7fKs6

  • Mashup Score: 0

    Call for Applications – HIVMA Board of Directors HIVMA is accepting applications from the membership for six open seats on the Board of Directors.  The Board of Directors provides critical input, oversight and guidance to strengthen HIVMA’s programs and policy agenda. Members may submit an application from the Volunteer Opportunities page on MyIDSA (log-in required)….

    Tweet Tweets with this article
    • #HIVTwitter #IDTwitter Please consider applying for the @HIVMA Board of Directors. 6 seats,(2 leadership positions: v-chair, HIVMA rep to @IDSAInfo BOD) 4 BOD seats (1 ID MD, 2 non-ID HIV MDs,1 HIV clinical pharmacist) Help #EndTheHIVEpidemic! Pls RT https://t.co/KXKPQQm9HC

  • Mashup Score: 1

    Introduction: Pneumocystis Pneumonia (PCP) is a common opportunistic infection among people living with the human immunodeficiency virus (HIV). This study’s objective was to assess temporal trends in PCP epidemiology among hospitalized patients with HIV/AIDS in the US and to compare data for hospitalizations with HIV with PCP to those without PCP. Methods: The national inpatient sample (NIS) data…

    Tweet Tweets with this article
    • Key paper: mortality amongst people with PCP is still HIGH. The groups who need PCP prophylaxis extend far beyond people with advanced HIV & cotrimoxazole remains the treatment with best evidence - thanks Prof Rob Miller. Link here: https://t.co/rjXnolpG1B #IDtwitter #HIVtwitter https://t.co/anr6u6NJdm

  • Mashup Score: 1

    Globally, 51% of people with HIV are women.1 But until quite recently, women with HIV were often referred to as a special population or regarded as a subgroup in research analyses. This situation is beginning to change, possibly galvanised by the eruption of community anger around the dolutegravir teratogenicity scare.2 However, the legacy of this special status has led to persistent inequities…

    Tweet Tweets with this article
    • Happy #IWD Thanks to @TheLancetHIV for publishing @vanessa_apea and my #IWD commentary How can I Help ? To increase inclusion of women in #HIV research over the continuum from the researchers , study design through to the participants https://t.co/sioroHndxB #HIVtwitter https://t.co/ZHfolNuf4w